S&P Equity Research Stock Ratings and Recommendations

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at S&P Equity Research. These ratings and price targets were collected from pubilc media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by S&P Equity Research.

DateBrokerageActionCompany
Name
RatingPrice
Target
Impact on
Share Price
Actions
3/27/2018S&P Equity ResearchLowers TargetSears (SHLD)$2.59 -> $2.30HighView Rating Details  Share on Twitter  Share on StockTwits
1/25/2018S&P Equity ResearchLowers TargetMannKind (MNKD)$3.49 -> $2.77HighView Rating Details  Share on Twitter  Share on StockTwits
1/24/2018S&P Equity ResearchRaises TargetConatus Pharmaceuticals (CNAT)$5.02 -> $5.69HighView Rating Details  Share on Twitter  Share on StockTwits
1/17/2018S&P Equity ResearchLowers TargetAcura Pharmaceuticals (ACUR)$0.74 -> $0.58HighView Rating Details  Share on Twitter  Share on StockTwits
1/11/2018S&P Equity ResearchLowers TargetNeuralstem (CUR)$2.26 -> $1.91LowView Rating Details  Share on Twitter  Share on StockTwits
1/10/2018S&P Equity ResearchLowers TargetNovavax (NVAX)$1.81 -> $1.35HighView Rating Details  Share on Twitter  Share on StockTwits
12/11/2017S&P Equity ResearchInitiatesSPDR S&P 500 ETF Trust (SPY) $3,000.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/20/2017S&P Equity ResearchLowers TargetRepros Therapeutics (RPRX)$0.49 -> $0.39N/AView Rating Details  Share on Twitter  Share on StockTwits
11/2/2017S&P Equity ResearchRaises TargetMicroVision (MVIS)$1.75 -> $2.22N/AView Rating Details  Share on Twitter  Share on StockTwits
5/15/2017S&P Equity ResearchRaises TargetRex Energy (REXX)$3.92 -> $4.71LowView Rating Details  Share on Twitter  Share on StockTwits
5/8/2017S&P Equity ResearchLowers TargetMannKind (MNKD)$1.04 -> $0.83HighView Rating Details  Share on Twitter  Share on StockTwits
5/1/2017S&P Equity ResearchLowers TargetRex Energy (REXX)$5.00 -> $4.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/28/2017S&P Equity ResearchRaises TargetBioblast Pharma (ORPN)$2.80 -> $3.15LowView Rating Details  Share on Twitter  Share on StockTwits
3/24/2017S&P Equity ResearchLowers TargetWestport Fuel Systems (WPRT)$1.00 -> $0.88LowView Rating Details  Share on Twitter  Share on StockTwits
3/15/2017S&P Equity ResearchRaises TargetDragonWave (DRWIQ)$1.50 -> $1.70LowView Rating Details  Share on Twitter  Share on StockTwits
3/10/2017S&P Equity ResearchRaises TargetTrovaGene (TROV)$1.55 -> $1.80N/AView Rating Details  Share on Twitter  Share on StockTwits
2/16/2017S&P Equity ResearchLowers TargetNeuralstem (CUR)$3.69 -> $3.18N/AView Rating Details  Share on Twitter  Share on StockTwits
2/10/2017S&P Equity ResearchUpgradesControl4 (CTRL)Market Perform -> Outperform $17.00N/AView Rating Details  Share on Twitter  Share on StockTwits
1/30/2017S&P Equity ResearchRaises TargetRepros Therapeutics (RPRX)$1.22 -> $1.50N/AView Rating Details  Share on Twitter  Share on StockTwits
1/20/2017S&P Equity ResearchDowngradesForeign Trade Bank of Latin America (BLX)Buy -> HoldN/AView Rating Details  Share on Twitter  Share on StockTwits
1/19/2017S&P Equity ResearchReiteratesUnited Continental (UAL)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
1/12/2017S&P Equity ResearchReiteratesInterpublic Group of Companies (IPG)ReduceN/AView Rating Details  Share on Twitter  Share on StockTwits
1/9/2017S&P Equity ResearchLowers TargetEnteroMedics (RSLS)$17.19 -> $11.06N/AView Rating Details  Share on Twitter  Share on StockTwits
12/29/2016S&P Equity ResearchRaises TargetMelinta Therapeutics (MLNT)$2.65 -> $3.15N/AView Rating Details  Share on Twitter  Share on StockTwits
12/29/2016S&P Equity ResearchLowers TargetNvidia (NVDA)$90.00 -> $24.75N/AView Rating Details  Share on Twitter  Share on StockTwits
12/15/2016S&P Equity ResearchLowers TargetNorthwest Biotherapeutics (NWBO)$0.73 -> $0.61N/AView Rating Details  Share on Twitter  Share on StockTwits
12/1/2016S&P Equity ResearchUpgradesLockheed Martin (LMT)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
12/1/2016S&P Equity ResearchUpgradesGeneral Dynamics (GD)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
11/29/2016S&P Equity ResearchRaises TargetCHF Solutions (CHFS)$0.18 -> $0.23N/AView Rating Details  Share on Twitter  Share on StockTwits
11/23/2016S&P Equity ResearchLowers TargetTCP International (TCPIF)$1.26 -> $1.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/21/2016S&P Equity ResearchLowers TargetRXi Pharmaceuticals (RXII)$23.50 -> $17.10N/AView Rating Details  Share on Twitter  Share on StockTwits
11/18/2016S&P Equity ResearchLowers TargetMicrobot Medical (MBOT)$1.36 -> $1.15N/AView Rating Details  Share on Twitter  Share on StockTwits
11/3/2016S&P Equity ResearchReiteratesWelltower (WELL)PositiveN/AView Rating Details  Share on Twitter  Share on StockTwits
10/27/2016S&P Equity ResearchReiteratesTesla (TSLA)SellN/AView Rating Details  Share on Twitter  Share on StockTwits
10/20/2016S&P Equity ResearchLowers TargetDragonWave (DRWIQ)$4.67 -> $3.36N/AView Rating Details  Share on Twitter  Share on StockTwits
10/17/2016S&P Equity ResearchRaises TargetOmeros (OMER)$7.65 -> $8.63N/AView Rating Details  Share on Twitter  Share on StockTwits
10/7/2016S&P Equity ResearchRaises TargetIdera Pharmaceuticals (IDRA)$1.86 -> $2.10N/AView Rating Details  Share on Twitter  Share on StockTwits
10/6/2016S&P Equity ResearchRaises TargetMicrobot Medical (MBOT)$1.07 -> $1.20N/AView Rating Details  Share on Twitter  Share on StockTwits
9/30/2016S&P Equity ResearchLowers TargetMolecular Templates (MTEM)$7.37 -> $5.72N/AView Rating Details  Share on Twitter  Share on StockTwits
9/28/2016S&P Equity ResearchRaises TargetExelixis (EXEL)$13.41 -> $15.57N/AView Rating Details  Share on Twitter  Share on StockTwits
9/27/2016S&P Equity ResearchReiteratesGeneral Mills (GIS)Buy $70.00N/AView Rating Details  Share on Twitter  Share on StockTwits
9/23/2016S&P Equity ResearchLowers TargetBioLineRx (BLRX)$1.24 -> $1.10N/AView Rating Details  Share on Twitter  Share on StockTwits
9/22/2016S&P Equity ResearchLowers TargetPalatin Technologies (PTN)$0.61 -> $0.55N/AView Rating Details  Share on Twitter  Share on StockTwits
9/20/2016S&P Equity ResearchLowers TargetSLS International (SLS)$0.39 -> $0.34N/AView Rating Details  Share on Twitter  Share on StockTwits
9/16/2016S&P Equity ResearchLowers TargetNovavax (NVAX)$1.44 -> $1.17N/AView Rating Details  Share on Twitter  Share on StockTwits
9/15/2016S&P Equity ResearchReiteratesMonsanto (MON)PositiveN/AView Rating Details  Share on Twitter  Share on StockTwits
9/14/2016S&P Equity ResearchLowers TargetMicrobot Medical (MBOT)$1.57 -> $1.31N/AView Rating Details  Share on Twitter  Share on StockTwits
9/13/2016S&P Equity ResearchLowers TargetNorthwest Biotherapeutics (NWBO)$0.59 -> $0.43N/AView Rating Details  Share on Twitter  Share on StockTwits
9/8/2016S&P Equity ResearchRaises TargetRepros Therapeutics (RPRX)$2.12 -> $2.47N/AView Rating Details  Share on Twitter  Share on StockTwits
9/8/2016S&P Equity ResearchReiteratesFinancial Select Sector SPDR Fund (XLF)OverweightN/AView Rating Details  Share on Twitter  Share on StockTwits
9/8/2016S&P Equity ResearchReiteratesApple (AAPL)Strong-BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
9/7/2016S&P Equity ResearchLowers TargetRosetta Genomics (ROSG)$0.94 -> $0.82N/AView Rating Details  Share on Twitter  Share on StockTwits
9/2/2016S&P Equity ResearchRaises TargetDynavax Technologies (DVAX)$11.28 -> $16.01N/AView Rating Details  Share on Twitter  Share on StockTwits
8/31/2016S&P Equity ResearchLowers TargetMannKind (MNKD)$0.84 -> $0.70N/AView Rating Details  Share on Twitter  Share on StockTwits
8/31/2016S&P Equity ResearchReiteratesBank of America (BAC)Buy $18.00N/AView Rating Details  Share on Twitter  Share on StockTwits
8/30/2016S&P Equity ResearchLowers TargetKaryopharm Therapeutics (KPTI)$9.06 -> $7.55N/AView Rating Details  Share on Twitter  Share on StockTwits
8/25/2016S&P Equity ResearchReiteratesNetflix (NFLX)Buy $128.00N/AView Rating Details  Share on Twitter  Share on StockTwits
8/24/2016S&P Equity ResearchLowers TargetTG Therapeutics (TGTX)$7.15 -> $6.40N/AView Rating Details  Share on Twitter  Share on StockTwits
8/21/2016S&P Equity ResearchSet Price TargetApplied Materials (AMAT)Hold $31.00N/AView Rating Details  Share on Twitter  Share on StockTwits
8/19/2016S&P Equity ResearchLowers TargetApollo Endosurgery (APEN)$3.15 -> $2.45N/AView Rating Details  Share on Twitter  Share on StockTwits
8/18/2016S&P Equity ResearchReiteratesChesapeake Energy (CHK)HoldN/AView Rating Details  Share on Twitter  Share on StockTwits
8/16/2016S&P Equity ResearchLowers TargetMicrobot Medical (MBOT)$1.77 -> $0.45N/AView Rating Details  Share on Twitter  Share on StockTwits
8/8/2016S&P Equity ResearchLowers TargetTellurian (TELL)$4.00 -> $3.40N/AView Rating Details  Share on Twitter  Share on StockTwits
8/6/2016S&P Equity ResearchSet Price TargetEnergy Transfer Partners (ETP)Hold $43.00N/AView Rating Details  Share on Twitter  Share on StockTwits
8/5/2016S&P Equity ResearchDowngradesFirst Solar (FSLR)Buy -> Hold$75.00 -> $55.00N/AView Rating Details  Share on Twitter  Share on StockTwits
7/27/2016S&P Equity ResearchReiteratesGilead Sciences (GILD)Strong-BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
7/24/2016S&P Equity ResearchSet Price TargetAT&T (T)Buy $46.00N/AView Rating Details  Share on Twitter  Share on StockTwits
7/25/2016S&P Equity ResearchReiteratesVanguard Real Estate ETF (VNQ)Equal WeightN/AView Rating Details  Share on Twitter  Share on StockTwits
7/24/2016S&P Equity ResearchUpgradesTesla (TSLA)Sell -> Hold $200.00N/AView Rating Details  Share on Twitter  Share on StockTwits
7/12/2016S&P Equity ResearchLowers TargetCytRx (CYTR)$6.24 -> $4.50N/AView Rating Details  Share on Twitter  Share on StockTwits
7/5/2016S&P Equity ResearchUpgradesThe Hershey (HSY)Hold -> Buy$94.00 -> $126.00N/AView Rating Details  Share on Twitter  Share on StockTwits
7/1/2016S&P Equity ResearchLowers TargetSLS International (SLS)$0.61 -> $0.50N/AView Rating Details  Share on Twitter  Share on StockTwits
6/30/2016S&P Equity ResearchReiteratesLions Gate Entertainment (LGF)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
6/24/2016S&P Equity ResearchLowers TargetMicrobot Medical (MBOT)$0.39 -> $0.33N/AView Rating Details  Share on Twitter  Share on StockTwits
6/17/2016S&P Equity ResearchLowers TargetMicrobot Medical (MBOT)$0.42 -> $0.35N/AView Rating Details  Share on Twitter  Share on StockTwits
6/15/2016S&P Equity ResearchReiteratesMBIA (MBI)PositiveN/AView Rating Details  Share on Twitter  Share on StockTwits
5/29/2016S&P Equity ResearchReiteratesValeant Pharmaceuticals International (VRX)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
5/20/2016S&P Equity ResearchReiteratesTesla (TSLA)SellN/AView Rating Details  Share on Twitter  Share on StockTwits
5/13/2016S&P Equity ResearchDowngradesFossil Group (FOSL)Buy -> Strong Sell $22.00N/AView Rating Details  Share on Twitter  Share on StockTwits
5/11/2016S&P Equity ResearchLowers TargetMicrobot Medical (MBOT)$3.59 -> $2.99N/AView Rating Details  Share on Twitter  Share on StockTwits
4/30/2016S&P Equity ResearchReiteratesAbbott Laboratories (ABT)HoldN/AView Rating Details  Share on Twitter  Share on StockTwits
5/1/2016S&P Equity ResearchReiteratesFord Motor (F)Strong-Buy $18.00N/AView Rating Details  Share on Twitter  Share on StockTwits
4/27/2016S&P Equity ResearchLowers TargetMicrobot Medical (MBOT)$3.72 -> $3.24N/AView Rating Details  Share on Twitter  Share on StockTwits
4/27/2016S&P Equity ResearchReiteratesProcter & Gamble (PG)Hold $85.00N/AView Rating Details  Share on Twitter  Share on StockTwits
4/23/2016S&P Equity ResearchReiteratesApple (AAPL)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
4/21/2016S&P Equity ResearchRaises TargetEnergy XXI Gulf Coast (EGC)$0.14 -> $0.17N/AView Rating Details  Share on Twitter  Share on StockTwits
4/17/2016S&P Equity ResearchDowngradesAltaba (AABA)HoldN/AView Rating Details  Share on Twitter  Share on StockTwits
4/12/2016S&P Equity ResearchReiteratesPfizer (PFE)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
4/12/2016S&P Equity ResearchReiteratesAllergan (AGN)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
3/31/2016S&P Equity ResearchReiteratesApple (AAPL)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
3/31/2016S&P Equity ResearchReiteratesThe Cheesecake Factory (CAKE)Hold $53.00N/AView Rating Details  Share on Twitter  Share on StockTwits
3/28/2016S&P Equity ResearchRaises TargetXilinx (XLNX)Strong-Buy$51.00 -> $54.00N/AView Rating Details  Share on Twitter  Share on StockTwits
3/28/2016S&P Equity ResearchRaises TargetITV (ITV)BuyGBX 200 -> GBX 240N/AView Rating Details  Share on Twitter  Share on StockTwits
3/24/2016S&P Equity ResearchDowngradesTesla (TSLA)Hold -> Sell $155.00N/AView Rating Details  Share on Twitter  Share on StockTwits
3/23/2016S&P Equity ResearchLowers TargetPernix Therapeutics (PTX)$1.37 -> $1.12N/AView Rating Details  Share on Twitter  Share on StockTwits
3/22/2016S&P Equity ResearchLowers TargetAkorn (AKRX)$25.98 -> $21.97N/AView Rating Details  Share on Twitter  Share on StockTwits
3/21/2016S&P Equity ResearchLowers TargetOvaScience (OVAS)$10.82 -> $8.83N/AView Rating Details  Share on Twitter  Share on StockTwits
3/16/2016S&P Equity ResearchReiteratesValeant Pharmaceuticals International (VRX)Buy$90.00 -> $30.00N/AView Rating Details  Share on Twitter  Share on StockTwits
3/7/2016S&P Equity ResearchLowers TargetBreitBurn Energy Partners (BBEPQ)$1.13 -> $0.80N/AView Rating Details  Share on Twitter  Share on StockTwits
2/29/2016S&P Equity ResearchRaises TargetNorthwest Biotherapeutics (NWBO)$1.80 -> $2.10N/AView Rating Details  Share on Twitter  Share on StockTwits
2/22/2016S&P Equity ResearchReiteratesBerkshire Hathaway (BRK.B)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
2/23/2016S&P Equity ResearchReiteratesBerkshire Hathaway (BRK.A)Buy $157.00N/AView Rating Details  Share on Twitter  Share on StockTwits
2/19/2016S&P Equity ResearchReiteratesApplied Materials (AMAT)HoldN/AView Rating Details  Share on Twitter  Share on StockTwits
2/18/2016S&P Equity ResearchSet Price TargetRWE (RWE)Buy €12.00N/AView Rating Details  Share on Twitter  Share on StockTwits
2/18/2016S&P Equity ResearchSet Price TargetBeiersdorf (BEI)Neutral €85.00N/AView Rating Details  Share on Twitter  Share on StockTwits
2/17/2016S&P Equity ResearchSet Price TargetSchneider Electric (SU)Sell €48.00N/AView Rating Details  Share on Twitter  Share on StockTwits
2/16/2016S&P Equity ResearchSet Price TargetHeidelbergCement (HEI)Neutral €70.00N/AView Rating Details  Share on Twitter  Share on StockTwits
2/16/2016S&P Equity ResearchSet Price TargetOrange (ORA)Buy €17.50N/AView Rating Details  Share on Twitter  Share on StockTwits
2/16/2016S&P Equity ResearchSet Price TargetMichelin (ML)Buy €95.00N/AView Rating Details  Share on Twitter  Share on StockTwits
2/15/2016S&P Equity ResearchReiteratesReckitt Benckiser (RBGLY)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
2/12/2016S&P Equity ResearchSet Price TargetRenault (RNO)Buy €86.00N/AView Rating Details  Share on Twitter  Share on StockTwits
2/12/2016S&P Equity ResearchSet Price TargetCommerzbank (CBK)Buy €8.00N/AView Rating Details  Share on Twitter  Share on StockTwits
2/12/2016S&P Equity ResearchSet Price TargetAlcatel Lucent (ALU)Buy €3.58N/AView Rating Details  Share on Twitter  Share on StockTwits
2/12/2016S&P Equity ResearchReiteratesBoeing (BA)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
2/12/2016S&P Equity ResearchSet Price TargetTotal (FP)Buy €40.00N/AView Rating Details  Share on Twitter  Share on StockTwits
2/11/2016S&P Equity ResearchSet Price TargetGlencore (GLEN)Sell GBX 65N/AView Rating Details  Share on Twitter  Share on StockTwits
2/11/2016S&P Equity ResearchSet Price TargetSoci�t� G�n�rale (GLE)Neutral €30.00N/AView Rating Details  Share on Twitter  Share on StockTwits
2/11/2016S&P Equity ResearchSet Price TargetAdidas (ADS)Buy €95.00N/AView Rating Details  Share on Twitter  Share on StockTwits
2/11/2016S&P Equity ResearchReiteratesTwitter (TWTR)Strong-Buy $40.00N/AView Rating Details  Share on Twitter  Share on StockTwits
2/10/2016S&P Equity ResearchReiteratesThe Walt Disney (DIS)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
2/10/2016S&P Equity ResearchSet Price TargetUniCredit (UCG)Neutral €3.00N/AView Rating Details  Share on Twitter  Share on StockTwits
2/9/2016S&P Equity ResearchSet Price TargetSanofi (SAN)Buy €85.00N/AView Rating Details  Share on Twitter  Share on StockTwits
2/8/2016S&P Equity ResearchLowers TargetCTI BioPharma (CTIC)$4.80 -> $3.90N/AView Rating Details  Share on Twitter  Share on StockTwits
2/5/2016S&P Equity ResearchReiteratesMerck & Co. (MRK)Hold $56.00N/AView Rating Details  Share on Twitter  Share on StockTwits
2/5/2016S&P Equity ResearchSet Price TargetIntesa Sanpaolo (ISP)Buy €2.80N/AView Rating Details  Share on Twitter  Share on StockTwits
2/5/2016S&P Equity ResearchSet Price TargetArcelorMittal (MT)Sell €9.60N/AView Rating Details  Share on Twitter  Share on StockTwits
2/5/2016S&P Equity ResearchSet Price TargetVinci (DG)Neutral €65.00N/AView Rating Details  Share on Twitter  Share on StockTwits
2/5/2016S&P Equity ResearchSet Price TargetBNP Paribas (BNP)Buy €47.00N/AView Rating Details  Share on Twitter  Share on StockTwits
2/4/2016S&P Equity ResearchSet Price TargetRoyal Dutch Shell (RDSB)Neutral GBX 1,622N/AView Rating Details  Share on Twitter  Share on StockTwits
2/4/2016S&P Equity ResearchSet Price TargetDaimler (DAI)Buy €77.00N/AView Rating Details  Share on Twitter  Share on StockTwits
2/4/2016S&P Equity ResearchSet Price TargetAstraZeneca (AZN)Neutral GBX 4,500N/AView Rating Details  Share on Twitter  Share on StockTwits
2/4/2016S&P Equity ResearchSet Price TargetING Group (INGA)Buy €12.00N/AView Rating Details  Share on Twitter  Share on StockTwits
2/4/2016S&P Equity ResearchSet Price TargetBanco Bilbao Vizcaya Argentaria (BBVA)Neutral €6.00N/AView Rating Details  Share on Twitter  Share on StockTwits
2/3/2016S&P Equity ResearchRaises TargetUni-Pixel (UNXLQ)$0.40 -> $0.45N/AView Rating Details  Share on Twitter  Share on StockTwits
2/3/2016S&P Equity ResearchInitiatesGilead Sciences (GILD)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
2/3/2016S&P Equity ResearchSet Price TargetLVMH (MC)Buy €170.00N/AView Rating Details  Share on Twitter  Share on StockTwits
2/2/2016S&P Equity ResearchSet Price TargetInfineon Technologies (IFXA)Buy €13.00N/AView Rating Details  Share on Twitter  Share on StockTwits
2/1/2016S&P Equity ResearchSet Price TargetBT Group (BT.A)Sell GBX 475N/AView Rating Details  Share on Twitter  Share on StockTwits
1/28/2016S&P Equity ResearchReiteratesAmazon.com (AMZN)Buy $685.00N/AView Rating Details  Share on Twitter  Share on StockTwits
1/28/2016S&P Equity ResearchReiteratesFord Motor (F)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
1/29/2016S&P Equity ResearchLowers TargetOXiGENE (MATN)$0.64 -> $0.58N/AView Rating Details  Share on Twitter  Share on StockTwits
1/29/2016S&P Equity ResearchSet Price TargetBG Group (BG)Neutral GBX 1,000N/AView Rating Details  Share on Twitter  Share on StockTwits
1/29/2016S&P Equity ResearchSet Price TargetDeutsche Bank (DBK)Sell €15.50N/AView Rating Details  Share on Twitter  Share on StockTwits
1/28/2016S&P Equity ResearchReiteratesIntercept Pharmaceuticals (ICPT)Average$100.60 -> $111.91N/AView Rating Details  Share on Twitter  Share on StockTwits
1/28/2016S&P Equity ResearchSet Price TargetBASF (BAS)Sell €57.00N/AView Rating Details  Share on Twitter  Share on StockTwits
1/28/2016S&P Equity ResearchSet Price TargetSalzgitter (SZG)Sell €19.00N/AView Rating Details  Share on Twitter  Share on StockTwits
1/27/2016S&P Equity ResearchLowers TargetMannKind (MNKD)$1.12 -> $0.96N/AView Rating Details  Share on Twitter  Share on StockTwits
1/27/2016S&P Equity ResearchUpgradeseasyJet (EZJ)Buy GBX 1,900N/AView Rating Details  Share on Twitter  Share on StockTwits
1/26/2016S&P Equity ResearchSet Price TargetSiemens (SIE)Neutral €94.00N/AView Rating Details  Share on Twitter  Share on StockTwits
1/25/2016S&P Equity ResearchRaises TargetPalatin Technologies (PTN)$0.57 -> $0.62N/AView Rating Details  Share on Twitter  Share on StockTwits
1/25/2016S&P Equity ResearchDowngradesWhole Foods Market (WFM)Underperform$23.00 -> $26.00N/AView Rating Details  Share on Twitter  Share on StockTwits
1/22/2016S&P Equity ResearchSet Price TargetSAP (SAP)Buy €76.00N/AView Rating Details  Share on Twitter  Share on StockTwits
1/21/2016S&P Equity ResearchSet Price TargetRoyal Dutch Shell (RDSB)Neutral GBX 1,385N/AView Rating Details  Share on Twitter  Share on StockTwits
1/21/2016S&P Equity ResearchSet Price TargetDeutsche Bank (DBK)Neutral €19.00N/AView Rating Details  Share on Twitter  Share on StockTwits
1/21/2016S&P Equity ResearchSet Price TargetBG Group (BG)Buy GBX 1,000N/AView Rating Details  Share on Twitter  Share on StockTwits
1/21/2016S&P Equity ResearchReiteratesBHP Billiton (BLT)Hold GBX 700N/AView Rating Details  Share on Twitter  Share on StockTwits
1/19/2016S&P Equity ResearchSet Price TargetRio Tinto (RIO)Neutral GBX 1,800N/AView Rating Details  Share on Twitter  Share on StockTwits
1/18/2016S&P Equity ResearchReiteratesTransAlta (TA)Hold C$8.00N/AView Rating Details  Share on Twitter  Share on StockTwits
1/15/2016S&P Equity ResearchSet Price TargetCarrefour (CA)Buy €30.00N/AView Rating Details  Share on Twitter  Share on StockTwits
1/15/2016S&P Equity ResearchReiteratesBHP Billiton (BLT)Hold GBX 700N/AView Rating Details  Share on Twitter  Share on StockTwits
1/15/2016S&P Equity ResearchSet Price TargetBeiersdorf (BEI)Buy €95.00N/AView Rating Details  Share on Twitter  Share on StockTwits
1/14/2016S&P Equity ResearchSet Price TargetAlstom (ALO)Buy €31.00N/AView Rating Details  Share on Twitter  Share on StockTwits
1/13/2016S&P Equity ResearchSet Price TargetAirbus (AIR)Buy €70.00N/AView Rating Details  Share on Twitter  Share on StockTwits
1/12/2016S&P Equity ResearchReiteratesShire (SHP)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
1/8/2016S&P Equity ResearchUpgradesJ C Penney (JCP)Hold -> BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
12/17/2015S&P Equity ResearchUpgradesSunPower (SPWR)Buy -> Strong-BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
12/17/2015S&P Equity ResearchUpgradesFirst Solar (FSLR)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
12/16/2015S&P Equity ResearchReiteratesPetrofac (PFC)Buy GBX 1,000N/AView Rating Details  Share on Twitter  Share on StockTwits
12/11/2015S&P Equity ResearchSet Price TargetMerck Group (MRK)Neutral €104.00N/AView Rating Details  Share on Twitter  Share on StockTwits
12/10/2015S&P Equity ResearchSet Price TargetInditex (ITX)Neutral €34.00N/AView Rating Details  Share on Twitter  Share on StockTwits
12/9/2015S&P Equity ResearchSet Price Targetthyssenkrupp (TKA)Neutral €21.00N/AView Rating Details  Share on Twitter  Share on StockTwits
12/3/2015S&P Equity ResearchReiteratesExxonMobil (XOM)Hold $95.00N/AView Rating Details  Share on Twitter  Share on StockTwits
12/3/2015S&P Equity ResearchReiteratesAT&T (T)Buy $41.00N/AView Rating Details  Share on Twitter  Share on StockTwits
12/2/2015S&P Equity ResearchSet Price TargetRWE (RWE)Buy €15.00N/AView Rating Details  Share on Twitter  Share on StockTwits
12/1/2015S&P Equity ResearchSet Price TargetThe Linde Group (LIN)Sell €135.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/30/2015S&P Equity ResearchSet Price TargetBHP Billiton (BLT)Neutral GBX 900N/AView Rating Details  Share on Twitter  Share on StockTwits
11/26/2015S&P Equity ResearchUpgradesRegal Entertainment Group (RGC)Hold -> Buy$15.00 -> $16.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/26/2015S&P Equity ResearchLowers TargetMolina Healthcare (MOH)Hold$32.00 -> $30.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/26/2015S&P Equity ResearchDowngradesAlnylam Pharmaceuticals (ALNY)Buy -> HoldN/AView Rating Details  Share on Twitter  Share on StockTwits
11/26/2015S&P Equity ResearchSet Price TargetInfineon Technologies (IFXA)Buy €13.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/25/2015S&P Equity ResearchReiteratesJohn Deere (DE)SellN/AView Rating Details  Share on Twitter  Share on StockTwits
11/25/2015S&P Equity ResearchSet Price TargetAllianz (ALV)Neutral €160.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/19/2015S&P Equity ResearchSet Price Targetthyssenkrupp (TKA)Neutral €21.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/12/2015S&P Equity ResearchSet Price TargetSalzgitter (SZG)Sell €22.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/12/2015S&P Equity ResearchSet Price TargetSiemens (SIE)Neutral €100.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/12/2015S&P Equity ResearchSet Price TargetMerck Group (MRK)Neutral €104.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/11/2015S&P Equity ResearchSet Price TargetHenkel AG & Co KGaA (HEN3)Buy €116.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/11/2015S&P Equity ResearchSet Price TargetE.ON (EOAN)Buy €10.70N/AView Rating Details  Share on Twitter  Share on StockTwits
11/11/2015S&P Equity ResearchSet Price TargetDeutsche Post (DPW)Sell €25.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/11/2015S&P Equity ResearchSet Price TargetVivendi (VIV)Neutral €22.40N/AView Rating Details  Share on Twitter  Share on StockTwits
11/10/2015S&P Equity ResearchSet Price TargetSanofi (SAN)Buy €95.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/6/2015S&P Equity ResearchSet Price TargetAllianz (ALV)Neutral €160.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/6/2015S&P Equity ResearchSet Price TargetArcelorMittal (MT)Sell €14.10N/AView Rating Details  Share on Twitter  Share on StockTwits
11/6/2015S&P Equity ResearchSet Price TargetHeidelbergCement (HEI)Buy €80.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/6/2015S&P Equity ResearchSet Price TargetAlstom (ALO)Buy €34.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/5/2015S&P Equity ResearchSet Price TargetAdidas (ADS)Neutral €84.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/5/2015S&P Equity ResearchSet Price TargetSoci�t� G�n�rale (GLE)Neutral €46.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/5/2015S&P Equity ResearchSet Price TargetDeutsche Telekom (DTE)Buy €19.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/4/2015S&P Equity ResearchSet Price TargetBeiersdorf (BEI)Buy €95.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/3/2015S&P Equity ResearchSet Price TargetBMW (BMW)Neutral €93.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/3/2015S&P Equity ResearchSet Price TargetCommerzbank (CBK)Neutral €11.80N/AView Rating Details  Share on Twitter  Share on StockTwits
11/3/2015S&P Equity ResearchUpgradesCVS Health (CVS)Strong-Buy $121.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/2/2015S&P Equity ResearchSet Price TargetStarwood Hotels & Resorts Worldwide (HOT) $85.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/2/2015S&P Equity ResearchReiteratesCVS Health (CVS)Strong-Buy $112.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/2/2015S&P Equity ResearchReiteratesColgate-Palmolive (CL)Hold $69.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/2/2015S&P Equity ResearchUpgradesEMC (EMC)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
11/2/2015S&P Equity ResearchSet Price TargetHSBC (HSBA)Buy GBX 600N/AView Rating Details  Share on Twitter  Share on StockTwits
10/30/2015S&P Equity ResearchSet Price TargetAirbus (AIR)Buy €72.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/30/2015S&P Equity ResearchRaises TargetStarbucks (SBUX)Buy$65.00 -> $68.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/30/2015S&P Equity ResearchDowngradesMastercard (MA)Hold $103.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/30/2015S&P Equity ResearchReiteratesAllergan (AGN)Buy $385.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/30/2015S&P Equity ResearchSet Price TargetBG Group (BG)Buy GBX 1,175N/AView Rating Details  Share on Twitter  Share on StockTwits
10/30/2015S&P Equity ResearchSet Price TargetRenault (RNO)Buy €99.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/30/2015S&P Equity ResearchSet Price TargetLufthansa (LHA)Sell €12.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/30/2015S&P Equity ResearchSet Price TargetSchneider Electric (SU)Neutral €57.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/29/2015S&P Equity ResearchSet Price TargetBayer (BAYN)Buy €147.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/29/2015S&P Equity ResearchSet Price TargetFresenius Medical Care (FME)Neutral €79.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/29/2015S&P Equity ResearchReiteratesWalgreens Boots Alliance (WBA)Buy $99.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/29/2015S&P Equity ResearchReiteratesAmerican International Group (AIG)Buy $72.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/29/2015S&P Equity ResearchSet Price TargetDeutsche Bank (DBK)Neutral €27.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/29/2015S&P Equity ResearchSet Price TargetRoyal Dutch Shell (RDSB)Neutral GBX 1,780N/AView Rating Details  Share on Twitter  Share on StockTwits
10/29/2015S&P Equity ResearchSet Price TargetSTMicroelectronics (STM)Sell €6.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/29/2015S&P Equity ResearchSet Price TargetDeutsche Post (DPW)Sell €25.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/28/2015S&P Equity ResearchReiteratesReynolds American (RAI)Strong-Buy $55.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/28/2015S&P Equity ResearchReiteratesPfizer (PFE)Hold $40.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/28/2015S&P Equity ResearchDowngradesE I Du Pont De Nemours And Co (DD)SellN/AView Rating Details  Share on Twitter  Share on StockTwits
10/28/2015S&P Equity ResearchSet Price TargetVolkswagen Group (VOW3)Neutral €115.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/28/2015S&P Equity ResearchSet Price TargetBritish American Tobacco (BATS)Neutral GBX 4,200N/AView Rating Details  Share on Twitter  Share on StockTwits
10/28/2015S&P Equity ResearchSet Price TargetThe Linde Group (LIN)Sell €135.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/27/2015S&P Equity ResearchRaises TargetPulteGroup (PHM)Buy$20.00 -> $22.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/27/2015S&P Equity ResearchUpgradesLyondellBasell (LYB)Buy $103.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/27/2015S&P Equity ResearchReiteratesBroadcom (BRCM)Strong-Buy $62.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/27/2015S&P Equity ResearchSet Price TargetBASF (BAS)Sell €65.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/27/2015S&P Equity ResearchSet Price TargetMAN (MAN)Sell €81.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/26/2015S&P Equity ResearchSet Price TargetPeugeot (UG)Neutral €16.50N/AView Rating Details  Share on Twitter  Share on StockTwits
10/23/2015S&P Equity ResearchReiteratesMcDonald's (MCD)HoldN/AView Rating Details  Share on Twitter  Share on StockTwits
10/23/2015S&P Equity ResearchReiteratesUnion Pacific (UNP)Buy $112.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/23/2015S&P Equity ResearchDowngradesDow Chemical (DOW)Hold$54.00 -> $51.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/23/2015S&P Equity ResearchDowngradesPapa Murphy's (FRSH)Hold -> SellN/AView Rating Details  Share on Twitter  Share on StockTwits
10/23/2015S&P Equity ResearchDowngradesHudson City Bancorp (HCBK)Buy -> HoldN/AView Rating Details  Share on Twitter  Share on StockTwits
10/23/2015S&P Equity ResearchUpgradesElmira Savings Bank (ESBK)Hold -> BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
10/23/2015S&P Equity ResearchDowngradesCaterpillar (CAT)Sell$72.00 -> $64.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/22/2015S&P Equity ResearchRaises TargetAmerican Express (AXP)Hold$80.00 -> $81.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/22/2015S&P Equity ResearchSet Price TargetDaimler (DAI)Buy €95.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/21/2015S&P Equity ResearchLowers TargetIBM (IBM)Buy$178.00 -> $168.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/21/2015S&P Equity ResearchDowngradesMorgan Stanley (MS)Buy$48.00 -> $38.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/20/2015S&P Equity ResearchDowngradesAltaba (AABA)Buy $38.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/20/2015S&P Equity ResearchReiteratesHoneywell (HON)Hold $108.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/20/2015S&P Equity ResearchReiteratesGeneral Electric (GE)Buy $34.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/20/2015S&P Equity ResearchSet Price TargetSAP (SAP)Buy €76.00N/AView Rating Details  Share on Twitter  Share on StockTwits

This page was last refreshed on Sunday at 04:42 AM ET.

MarketBeat Community Rating for S&P Equity Research

Community Ranking:  0.0 out of 5 (star star star)
Outperform Votes:  0 (Vote Outperform)
Underperform Votes:  2,224 (Vote Underperform)
Total Votes:  2,224
MarketBeat's community ratings are surveys of what our community members think about S&P Equity Research and other research firms. Vote "Outperform" if you believe S&P Equity Research's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe S&P Equity Research's recmomendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.